Among the various transcripts downregulated in both cancer cell lines (242) was the SRF (serum response factor) mRNA encoding a transcriptional regulator modulating both proliferative and migratory/invasive tumor cell properties in a conserved manner, as previously demonstrated for IGF2BP1 (6,7). The gene discussed is IGF2BP1; the disease is neoplasm.